Treatment of Chronic Hepatitis C in a Patient Affected by Systemic Sclerosis
The currently recommended treatment for patients infected with hepatitis C virus (HCV) is pegilated interferon α (IFN α) plus ribavirin. Despite the numerous benefits of this therapy, there is an increasing concern regarding his tolerance. Among the most common side effects, interferon may trigger...
Saved in:
| Main Authors: | Guido Poggi, Laura Villani, Federico Sottotetti, Barbara Tagliaferri, Benedetta Montagna, Alessio Amatu, Giovanni Bernardo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2009-01-01
|
| Series: | Gastroenterology Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/2009/475390 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antiretroviral therapy does not affect response to chronic hepatitis C therapy in HIV-coinfected patients
by: Luciana Brosina de Leon, et al.
Published: (2016-08-01) -
Diagnosis and Management of Chronic Hepatitis C
by: Alajos Pár
Published: (2000-01-01) -
Betaleukin in therapy of chronic hepatitis C
by: E. S. Romanova, et al.
Published: (2014-10-01) -
Hyperferritinemia at the patient with chronic hepatitis C
by: Ye. N. German, et al.
Published: (2009-02-01) -
Repercussions of chronic hepatitis C treatment
by: Daniela Maria Falcão Oliveira, et al.
Published: (2018-03-01)